Allarity Therapeutics, Inc.
ALLR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,806 | -$2,320 | -$2,732 | -$7,453 |
| Dep. & Amort. | $0 | $12 | $11 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $164 | $139 | $0 |
| Change in WC | -$816 | -$3,420 | -$149 | $3,906 |
| Other Non-Cash | $212 | $83 | $45 | $340 |
| Operating Cash Flow | -$3,410 | -$5,481 | -$2,686 | -$3,206 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$298 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$298 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,451 | $0 | $11,143 | $4,235 |
| Stock Repurch. | -$141 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2,310 | -$2,565 | $11,143 | $4,235 |
| Forex Effect | $194 | -$1,857 | -$286 | $339 |
| Net Chg. in Cash | -$906 | -$9,903 | $8,171 | $1,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,801 | $27,704 | $19,533 | $18,463 |
| End Cash | $16,895 | $17,801 | $27,704 | $19,533 |
| Free Cash Flow | -$3,410 | -$5,481 | -$2,686 | -$3,504 |